Skip to main content

Advertisement

Log in

Long-term progression of retinal vasculitis in Behçet patients using a fluorescein angiography scoring system

  • Inflammatory Disorders
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Background

To evaluate the long-time progression of retinal vasculitis in Behçet patients using the fluorescein angiography (FA) scoring system.

Methods

Retrospective study was conducted for 71 eyes of 43 patients who met the study criteria. All patients completed at least 2 years of follow-up. FA was taken during the periods of active retinal vasculitis and the quiescent phase, and analyzed using a FA scoring system. Among nine categories, the four most prevalent FA signs were evaluated: optic disc hyperfluorescence (score 0–3), macular edema (score 0–4), retinal vascular staining and/or leakage (score 0–7), and capillary leakage (score 0–10).

Results

Mean number of total active inflammations was 2.6 ± 1.5 times during mean 55.0 ± 20.0 months. Mean scores at the first active inflammation were 1.8 ± 1.0 for optic disc hyperfluorescence, 2.4 ± 1.0 for macular edema, 5.3 ± 2.1 for retinal vascular staining and/or leakage, and 5.8 ± 3.2 for capillary leakage. Mean total FA score was 17.4 ± 6.8. Mean scores at the first quiescent phase were 0.6 ± 0.4 for optic disc hyperfluorescence, 1.1 ± 1.2 for macular edema, 3.8 ± 1.9 for retinal vascular staining and/or leakage, and 3.5 ± 3.5 for capillary leakage. Mean total FA score was 9.1 ± 5.0. Mean scores for each active inflammation and quiescent phase were not significantly changed, and mean FA scores were significantly reduced in quiescent phase (P = 0.003 for optic disc hyperfluorescence, P = 0.005 for macular leakage, P = 0.010 for retinal vascular staining and/or leakage, P = 0.008 for capillary leakage, and P = 0.018 for total FA score; paired t-test).

Conclusions

Retinal vasculitis of Behçet patients did not significantly progress during long-term follow-up.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Deuter CM, Kötter I, Wallace GR, Murray PI, Stübiger N, Zierhut M (2008) Behçet’s disease: ocular effects and treatment. Prog Retin Eye Res 27:111–136

    Article  CAS  PubMed  Google Scholar 

  2. George RK, Chan C, Whitcup SM, Nussenblatt RB (1997) Ocular immunopathology of Behçet’s disease. Surv Ophthalmol 42:157–162

    Article  CAS  PubMed  Google Scholar 

  3. Chajek T, Fainaru M (1975) Behçet’s disease. Report of 41 cases and a review of the literature. Medicine 54:179–196

    Article  CAS  PubMed  Google Scholar 

  4. Kontogianis V, Powell RJ (2000) Behçet’s disease. Postgrad Med J 76:629–637

    Article  Google Scholar 

  5. Wong RC, Ellis CN, Diaz LA (1984) Behçet’s disease. Int J Dermatol 23:25–32

    Article  CAS  PubMed  Google Scholar 

  6. Llopis MD, Cervera M, Menezo JL (1990) Cyclosporin A treatment of Behçet’s disease: a long term study. Curr Eye Res 9:17–23

    Article  Google Scholar 

  7. Evereklioglu C (2005) Current concepts in the etiology and treatment of Behçet’s disease. Surv Ophthalmol 50:297–350

    Article  PubMed  Google Scholar 

  8. Atmaca LS (1989) Fundus changes associated with Behçet’s disease. Graefes’s Arch Clin Exp Ophthalmol 227:340–344

    Article  CAS  Google Scholar 

  9. Atmaca LS, Batioglu F (1994) The efficacy of cyclosporine A in the treatment of Behçet’s disease. Ophthalmic Surg 25:321–327

    CAS  PubMed  Google Scholar 

  10. Ozdal PC, Ortaç S, Taşkintuna I, Taşkintuna I, Firat E (2001) Posterior segment involvement in ocular Behçet’s disease. Eur J Ophthalmol 12:424–431

    Google Scholar 

  11. Altenburg A, Papoustis N, Orawa H, Martus P, Krause L, Zouboulis CC (2006) Epidemiology and clinical manifestations of Adamantiades–Behçet’s disease in Germany—current pathogenetic concepts and therapeutic possibilities. J Dtsch Dermatol Ges 4:49–64

    Article  PubMed  Google Scholar 

  12. Yazici H, Tuzun Y, Pazarli H, Yurdakul S, Ozyazgan Y, Ozdoğan H, Serdaroğlu S, Ersanli M, Ulkü BY, Müftüoğlu AU (1984) Influence of age of onset and patient’s sex on prevalence and severity of manifestations of Behçet’s syndrome. Ann Rheum Dis 43:783–789

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Yazici H, Barnes CG (1991) Practical treatment recommendations for pharmacotherapy of Behçet’s syndrome. Drugs 42:796–804

    Article  CAS  PubMed  Google Scholar 

  14. Ben-Ezra D, Cohen E (1986) Treatment and visual prognosis in Behçet’s disease. Br J Ophthalmol 70:589–592

    Article  CAS  Google Scholar 

  15. Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Huseyin Altunbas H, Urgancioglu M (2004) Uveitis in Behçet’s disease: an analysis of 880 patients. Am J Ophthalmol 138:373–380

    Article  PubMed  Google Scholar 

  16. Atmaca LS, Sonmez PA (2003) Fluorescein and indocyanine green angiography findings in Behçet’s disease. Br J Ophthalmol 87:1466–1468

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  17. Gedik S, Akova Y, Yilmaz G, Bozbeyoğlu S (2005) Indocyanine green and fundus fluorescein angiographic findings in patients with active ocular Behçet’s disease. Ocular Immunol Inflamm 13:51–58

    Article  Google Scholar 

  18. Yu HG, Kim MJ, Oh FS (2009) Fluorescein angiography and visual acuity in active uveitis with Behçet’s disease. Ocular Immunol Inflamm 17:41–46

    Article  Google Scholar 

  19. Tugal-Tutkun I, Herbort CP, Khairallah M, The Angiography Scoring for Uveitis Working Group (ASUWOG) (2010) Scoring of dual fluorescein and ICG inflammatory angiographic signs for the grading of posterior segment inflammation (dual fluorescein and ICG angiographic scoring system for uveitis). Int Ophthalmol 30:539–553

    Article  PubMed  Google Scholar 

  20. The International Study Group for Behçet’s disease (1990) Criteria for diagnosis of Behçet’s disease. Lancet 1335:1078–1080

    Google Scholar 

  21. Jabs DA, Nussenblatt RB, Rosenbaum JT, The Standardization of Uveitis Nomenclature (SUN) Working Group (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol 140:509–516

    Article  PubMed  Google Scholar 

  22. Spitznas M (2006) Understanding fluorescein angiography. Springer, Berlin, pp 73–99

    Google Scholar 

  23. Nussenblatt R (2010) Uveitis: fundamentals and clinical practice, 4th edn. Elsevier, Philadelphia, pp 42–71

    Google Scholar 

  24. Verity DH, Vaughan RW, Madanat W, Kondeatis E, Zureikat H, Fayyad F, Kanawati CA, Ayesh I, Stanford MR, Wallace GR (1999) Factor V Leiden mutation is associated with ocular involvement in Behçet’s disease. Am J Ophthalmol 128:352–356

    Article  CAS  PubMed  Google Scholar 

  25. Takeuchi M, Hokama H, Tsukahara R, Kezuka T, Goto H, Sakai J, Usui M (2005) Risk and prognostic factors of poor visual outcome in Behçet’s disease with ocular involvement. Graefes Arch Clin Exp Ophthalmol 243:1147–1152

    Article  PubMed  Google Scholar 

  26. Gueudry J, Wechsler B, Terrada C, Gendron G, Cassoux N, Fardeau C, Lehoang P, Piette JC, Bodaghi B (2008) Long-term efficacy and safety of low-dose interferon alpha2a therapy in severe uveitis associated with Behçet disease. Am J Ophthalmol 146:837–844

    Article  CAS  PubMed  Google Scholar 

  27. Deuter CM, Zierhut M, Möhle A, Vonthein R, Stöbiger N, Kötter I (2010) Long-term remission after cessation of interferon-α treatment in patients with severe uveitis due to Behçet’s disease. Arthritis Rheum 62:2796–2805

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Funding/support

None

Financial disclosure

None

Contributions of authors

Design and conduct of study (HM Kang, SC Lee); collection of data (HM Kang); management, analysis, and interpretation of data (HM Kang and CS Lee); and preparation, review, and approval of the manuscript (HM Kang and SC Lee)

Conflict of interest

No authors have any financial/conflicting interests to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sung Chul Lee.

Additional information

The abstract of this article was presented as a poster in the 110th annual congress of the Korean Ophthalmological Society in KINTEX, Seoul, Republic of Korea, November, 2013

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kang, H.M., Lee, S.C. Long-term progression of retinal vasculitis in Behçet patients using a fluorescein angiography scoring system. Graefes Arch Clin Exp Ophthalmol 252, 1001–1008 (2014). https://doi.org/10.1007/s00417-014-2637-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-014-2637-z

Keywords

Navigation